SOPHiA GENETICS SA (SOPH) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

... ... Thank you. Thank you. Thank you. ... ... Good morning. My name is Vincent, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Sophia Genetics first quarter 2026 earnings conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. Kellen Sanger, Sophia Genetics VP of Strategy. You may begin. Thank you, and good morning, everyone. Welcome to the Sophia Genetics first quarter 2026 earnings conference call. Joining me today to discuss our results are Dr. Yergi Camblong, our co-founder and chief executive officer, Ross Muecken, our company president, and George Cardoza, our chief financial officer. I'd like to remind you that management will make statements during this call that are forward-looking statements within the meanings of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated, and you should not place undue reliance on forward-looking statements. Additional information regarding these risks, uncertainties, and factors that could cause results to differ appears in the press release issued by Sophia Genetics today and in the documents and reports filed by Sophia Genetics from time to time with the Securities and Exchange Commission. During this call, we will present both IFRS and non-IFRS financial measures. Reconciliation of IFRS and non-IFRS measures is included in today's earnings press release, which is available on our website. With that, I'll now turn the call over to Yurgi. Thanks, Kenan, and good morning, ...